Vianautis

Vianautis company information, Employees & Contact Information

Explore related pages

Related company profiles:

ViaNautis, formerly known as SomaServe, was founded in 2018 as a spin-off from UCL under the leadership of CEO and serial entrepreneur, Dr Francesca Crawford. The company’s core mission is to exploit the unique capabilities of the revolutionary polyNaut® technology. PolyNaut® is a versatile nano-engineered polymer technology designed for targeted intracellular delivery. This innovative technology enables polymer nanoparticles to deliver a wide range of payloads from small molecules to genetic materials creating ‘a bionic nanoparticle.’ The highly adaptable polymer structure of polyNaut® can be formulated to encapsulate a wide array of genetic cargoes, with sizes exceeding current standards for viral and non-viral delivery. Notably, it enhances the therapeutic efficacy of encapsulated molecules through direct delivery to the cell cytoplasm, facilitated by GOTO® technology for intracellular shuttling. PolyNaut® is set apart from conventional non-viral delivery technologies through its remarkable ability to target specific cells and penetrate biological barriers, including the challenging blood-brain barrier. PolyNaut® nanoparticles, when functionalised for CNS delivery through transcytosis, exhibit exceptional brain uptake. Deploying its state-of-the-art polyNaut® platform, ViaNautis is at the forefront of pioneering new therapies for CNS diseases and cystic fibrosis. The company is actively building an internal pipeline and collaborating with leading pharmaceutical and biotech companies to unlock the potential of promising genetic molecules as well as new therapeutic platforms.

Company Details

Employees
47
Address
Babraham Research Campus, Cambridge,cb22 3at,united Kingdom
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Cambridge
Looking for a particular Vianautis employee's phone or email?

Vianautis Questions

News

ViaNautis Bio Signs Strategic Collaboration Agreement with - GlobeNewswire

ViaNautis Bio Signs Strategic Collaboration Agreement with GlobeNewswire

Lilly Forms Strategic Collaboration with ViaNautis Bio to Develop Novel Genetic Cargo-based Therapeutics - BioPharm International

Lilly Forms Strategic Collaboration with ViaNautis Bio to Develop Novel Genetic Cargo-based Therapeutics BioPharm International

ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer - BioSpace

ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer BioSpace

ViaNautis moves to advance platform for genetic treatment delivery - Cystic Fibrosis News Today

ViaNautis moves to advance platform for genetic treatment delivery Cystic Fibrosis News Today

ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors - Yahoo Finance

ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Yahoo Finance

ViaNautis eyes fresh hires as it continues to grow - Business Weekly

ViaNautis eyes fresh hires as it continues to grow Business Weekly

ViaNautis raises Series A to drive the next generation of genetic nanomedicines - BGF

ViaNautis raises Series A to drive the next generation of genetic nanomedicines BGF

Nanoparticle drug delivery platform ViaNautis lands £20m - UKTN

Nanoparticle drug delivery platform ViaNautis lands £20m UKTN

ViaNautis Bio - Business Weekly

ViaNautis Bio Business Weekly

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant